ARCHIVES

Clinical Trial Pathology Improvements Recommended By Group Remaining Actions After Merit Review

This article is from The Cancer Letter archive.

Vol. 05 No. 02 | January 12, 1979

Download PDF Visit The Full Archive

Related Articles

Arizona First To Get Comprehensive Recognition Under New Guidelines; salmon Names Alberts As His Deputy, With Trent Going To Michigan

March 16, 1990

Mammography Quality Standards Set, FDA User Fees Enacted; Oral Cancer Drugs Covered

October 16, 1992

Salmon Enthusiastic About Comprehensive Core Grant Plan

May 6, 1988

NCCS Networker Volume 5 Issue 3, Summer 1991

June 13, 1991

DeVita’s “Radical” Statement – Resectability Rate Should Be The Cure Rate

October 1, 1976

GAO Report: Taxol CRADA “Successful,” But Not Great Financial Deal.

June 27, 2003